2.6
2023

Pruritus burden assessment in severe atopic dermatitis patients under dupilumab: response predictor?

Show more: Authors information and Publication history
Authors Information

1Department of Immunoallergology, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal
2Universitary Clinic of Immunoallergology, Faculty of Medicine, Universidade de Lisboa, Lisbon, Portugal 

History

Published: 28 July 2023
Accepted: 27 July 2023
Received: 12 May 2023

KEY WORDS
Anti-IL-4/IL-13; atopic dermatitis; dupilumab; pruritus.

Table of Content: Online First

European Annals of Allergy and Clinical Immunology ISSN 1764-1489 | © 2024